| Dr Herminio B Balderama, MD | |
|
8357 Memphis Arlington Rd, Bartlett, TN 38133-2138 | |
| (901) 371-0200 | |
| (901) 383-1178 |
| Full Name | Dr Herminio B Balderama |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Location | 8357 Memphis Arlington Rd, Bartlett, Tennessee |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861433377 | NPI | - | NPPES |
| 3051841 | Medicaid | TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | MD020213 (Tennessee) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Herminio B Balderama, MD 8357 Memphis Arlington Rd, Bartlett, TN 38133-2138 Ph: (901) 371-0200 | Dr Herminio B Balderama, MD 8357 Memphis Arlington Rd, Bartlett, TN 38133-2138 Ph: (901) 371-0200 |
News Archive
A proposal to sharply cut a drug discount program that many hospitals rely on drew some 1,400 comments when the Trump administration announced its plan last year. Hundreds appeared to come from patients across the country — pleas from average Americans whose treatments for diseases such as cancer depend on costly medicines.
Neuroscience researchers have zeroed in on a novel mechanism that helps control the firing of electrical signals among neurons. By isolating the molecular and electrical events that occur when this control is disrupted, the new research sheds light on epileptic seizures and potentially on other prominent diseases involving poorly regulated brain activity.
Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, announced today that it has submitted an investigational new drug (IND) amendment to the United States Food and Drug Administration (FDA) which includes the design of a proposed Phase 3 clinical trial of Neoprobe's RIGScan® CR radiopharmaceutical.
Researchers at Boston University School of Medicine (BUSM) have been part of a multicenter observational study called TRACS (Transthyretin Amyloidosis Cardiac Study) to help determine the health significance of a particular gene mutation which is commonly found in Black Americans.
› Verified 4 days ago
Shoaib Azam, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 3350 N Germantown Rd, Bartlett, TN 38133 Phone: 901-377-2111 Fax: 901-377-5105 | |
Dr. Ramon T Ungab, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2851 Stage Center Dr, Bartlett, TN 38134 Phone: 901-388-7711 Fax: 901-507-2280 | |
Dr. David Dale Sloas, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 3350 N Germantown Rd, Bartlett, TN 38133 Phone: 901-377-2111 Fax: 901-377-5105 | |
Dr. Raif Wassef Elsakr, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3350 N Germantown Rd, Bartlett, TN 38133 Phone: 901-377-2111 Fax: 901-377-5105 | |
Dr. Muhammad Saleem, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2686 Kate Bond Rd, Bartlett, TN 38133 Phone: 901-384-9920 | |
David Mark Stern, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 6630 Summer Knoll Cir Ste 101, Bartlett, TN 38134 Phone: 901-746-9438 Fax: 901-746-9331 | |
Wajih Istanbouli, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6570 Summer Oaks Cv, Bartlett, TN 38134 Phone: 901-373-7100 Fax: 901-842-0020 |